GILBERT 🫁

GILBERT 🫁 is a spin-off of Delft University of Technology (TU Delft) and a group of companies based at the High Tech Campus in Eindhoven, The Netherlands. The company's slogan "Redefining treatment for lung patients 💫" encapsulates its core mission, which is to make medical treatment easier and more effective for millions of lung patients, thereby extending and improving lives while reducing the burden of care on healthcare systems. At its heart, Gilbert is committed to delivering a social contribution to the well-being of people and stimulating healthcare improvements. The company leverages evolving technological applications to achieve these goals. Gilbert emphasizes the responsible gathering of scientific findings for product development and innovation in healthcare, with the aim of optimizing the overall healthcare landscape. Additionally, the company aims to allocate its revenues to facilitate further scientific research, emphasizing a commitment to continuous improvement and development. Taking a forward-looking approach, Gilbert is focused on developing the next generation of soft mist inhalers through its proprietary electrospray technology. This innovation aims to enhance treatment for patients with difficult-to-treat lung conditions, potentially making a significant impact on the field of respiratory medicine. It's noteworthy that Gilbert comprises subsidiaries like Gilbert Innovation, Gilbert Therapeutics, and Gilbert Technologies, representing a comprehensive approach to its technological and medical advancements. Founded in 2016, Gilbert operates at the intersection of science, technology, and healthcare, positioning itself as a key player in reshaping lung patient treatment. While specific investment details are not provided, the company's vision and technological advancements make it an intriguing prospect for potential venture capital investment, aligning with the growing demand for innovative healthcare solutions.